To amend title XXVII of the Public Health Service Act to establish civil liability for health insurance issuers with high levels of claims denials.

HR8442, titled "To amend title XXVII of the Public Health Service Act to establish civil liability for health insurance issuers with high levels of claims denials," was introduced on April 22, 2026, and subsequently referred to the House Committee on Energy and Commerce. This places the bill in the early stages of the legislative process, requiring committee review and potential amendments before it can advance to a floor vote. This bill does not authorize or appropriate any specific funding. Instead, its mechanism is regulatory, aiming to impose civil liability on health insurance issuers. This means that if enacted, the financial impact would stem from potential legal judgments, increased compliance costs, and changes in claims processing procedures for health insurers, rather than direct government spending or grants. The bill's intent is to create a disincentive for high claims denial rates by introducing financial penalties through civil lawsuits. Structural losers under this proposed legislation would primarily be health insurance issuers. Companies such as UnitedHealth Group ($UNH), Elevance Health, Humana ($HUM), Cigna ($CI), and CVS Health ($CVS), which operates Aetna, would face increased legal and operational risks. These companies would likely need to invest more in claims processing oversight, appeals processes, and legal defense to mitigate the new liability. There are no direct structural winners identified by this bill, as it focuses on regulatory enforcement within the insurance sector. The legislative path for HR8442 involves committee consideration, potential markups, and then a vote in the House. If passed by the House, it would then move to the Senate for similar consideration. Given its early stage and the potential for significant industry opposition, the timeline for its progression is uncertain and likely extended.